Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.86 % |
3 Month Return | + 3.57 % |
1 Year Return | + 1.03 % |
Market Stats | |
Previous Close | ₹20.60 |
Open | ₹20.75 |
Volume | 3,845.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹6.18Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹268.78 Cr |
P/B Ratio | 3.73 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 15.49 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹268.78 Cr | 222.61% | 0.73 | NA | NA | |
NA | ₹161.71 Cr | -2.06% | 0.64 | ₹9 Cr | ₹131 Cr | |
NA | ₹438.04 Cr | 90.35% | 0.60 | ₹5 Cr | ₹173 Cr | |
NA | ₹542.38 Cr | -3.63% | 0.54 | NA | NA | |
NA | ₹54.31 Cr | 153.06% | 0.81 | NA | NA |
Organisation | Brawn Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.64% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 46.01% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.5% return, outperforming this stock by 61.5%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 132.4% return, outperforming this stock by 123.7%
Price Dip
In the last 6 months, Brawn Biotech stock has moved down by -22.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 53.64% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0.35% | 0.00 | |
Retail Investors | 46.01% | 0.00 | |
Others | 0% | 0.00 |
Brawn Biotech Ltd’s net profit fell -300% since last year same period to ₹0.04Cr in the Q1 2023-2024. On a quarterly growth basis, Brawn Biotech Ltd has generated -117.39% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2018, Brawn Biotech Ltd has declared dividend of ₹1 - translating a dividend yield of 12.14%.
Read More about DividendsBearish
Neutral
Bullish
Brawn Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Brawn Biotech Ltd (530207) share price today is ₹20.69
Brawn Biotech Ltd is not listed on NSE
Brawn Biotech Ltd is listed on BSE
Today’s traded volume of Brawn Biotech Ltd(530207) is 3,845.00.
Today’s market capitalisation of Brawn Biotech Ltd(530207) is ₹6.18Cr.
Brawn Biotech Ltd(530207 | Price |
---|---|
52 Week High | ₹27.82 |
52 Week Low | ₹14.63 |
Brawn Biotech Ltd(530207) share price is ₹20.69. It is down -25.63% from its 52 Week High price of ₹27.82
Brawn Biotech Ltd(530207) share price is ₹20.69. It is up 41.42% from its 52 Week Low price of ₹14.63
Brawn Biotech Ltd(530207 | Returns |
---|---|
1 Day Returns | 0.09% |
1 Month Returns | -1.86% |
3 Month Returns | 3.57% |
1 Year Returns | 1.03% |